David Rubin

Professor

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Rubin is a Professor at the University of Chicago, specializing in inflammatory bowel diseases, particularly Ulcerative Colitis and Crohn’s Disease. His recent research includes studies on the effectiveness and safety of treatments, patient perspectives on disease impact, and the use of artificial intelligence in histopathology assessment. He is committed to advancing patient-centric approaches in clinical practice and therapy positioning.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Edward Loftus

Professor of Medicine

Mayo Clinic Rochester

UNITED STATES

View details

Tim Raine

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Jean Fred Colombel

Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

David Choi

University of Chicago Medicine

UNITED STATES

View details

Jan Niess

Prof.

University of Basel

SWITZERLAND

View details

Remo Panaccione

Director, Inflammatory Bowel disease Unit, Professor of Medicine

University of Calgary

CANADA

View details

Subrata Ghosh

University of Birmingham

UNITED KINGDOM

View details

Séverine Vermeire

University Hospitals Leuven

BELGIUM

View details

Angad Chadha

Physician / Asst Prof

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Rubin

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis

Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn’s Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey

Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease

A Guide to the Patient-Centric Use of Vedolizumab for Crohn’s Disease

Clinical Trials for Perianal Crohn’s Disease: A Call for a Revised Approach

Impact of moderate-to-severe ulcerative colitis and Crohn’s disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey

A practical approach to positioning therapies in ulcerative colitis

Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in UC: Analyses of the ELEVATE UC Clinical Programme

Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis

Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn’s Disease: Real World Data from a Tertiary Center

Risankizumab Effectiveness and Safety in Crohn’s Disease: Real-world Data From a Large Tertiary Center

Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme

Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives

Ozanimod-exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histological Changes

The evolving understanding of histology as an endpoint in ulcerative colitis

Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn’s Disease

Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease

Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States

Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States

Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension

(Re)Appraising Remission in Ulcerative Colitis

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis

Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme

A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index

Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center

Collaborators (9)

Edward Loftus

Tim Raine

Jean Fred Colombel

David Choi

Jan Niess

Remo Panaccione

Subrata Ghosh

Séverine Vermeire

Angad Chadha

Make your next move.